BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Novartis International AG Invests $65 Million to Develop Manufacturing

  September 28, 2007

   · 

  1 min read
• Policy

  Perrigo Company Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory Therapeutics

  September 28, 2007

   · 

  3 min read
• Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer

  September 28, 2007

   · 

  1 min read
• BioMidwest

  Takeda Pharmaceutical Co. Ltd.'s Actos and GlaxoSmithKline’s (Jobs) Avandia Heart Failure Risks Confirmed in Study

  September 28, 2007

   · 

  1 min read
• FDA

  Novartis International AG Diabetes Drug Galvus Approved in Europe

  September 28, 2007

   · 

  1 min read
• Policy

  CV Therapeutics, Inc. Submits Supplemental New Drug Application for Ranexa(R)

  September 28, 2007

   · 

  2 min read
• Business

  PAREXEL International Updates Financial Guidance

  September 28, 2007

   · 

  6 min read
• Drug Development

  Barrier Therapeutics, Inc. Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Hyphanox(TM) for Onychomycosis

  September 28, 2007

   · 

  1 min read
• Business

  XTend Medical (XMDC) Signs Exclusive Distribution Agreement With Diabetes Detection, Inc., a Silicon Valley Company

  September 28, 2007

   · 

  1 min read
• Business

  biolitec AG Record Profit in FY 2006/07 With a Growth of 191% to Euro 6,7 Million

  September 28, 2007

   · 

  3 min read